Topiramato / Topiramate
Bibliografía en Core Clinical Journals , Ensayos clínicos
Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
Arch Intern Med. 2005 Jul 25;165(14):1600-5. Johnson B.A., Ait-Daoud N., Akhtar F.Z., Javors M.A.
Assessing the ability of topiramate to improve the daily activities of patients with migraine.
Mayo Clin Proc. 2006 Oct;81(10):1311-9. Brandes J.L., Kudrow D.B., Rothrock J.F., Rupnow M.F., Fairclough D.L., Greenberg S.J.
Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
Neurology. 2005 Jun 28;64(12):2108-14. Meador K.J., Loring D.W., Vahle V.J., Ray P.G., Werz M.A., Fessler A.J., Ogrocki P., Schoenberg M.R., Miller J.M., Kustra R.P.
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
Arch Intern Med. 2008 Jun 9;168(11):1188-99. Johnson B.A., Rosenthal N., Capece J.A., Wiegand F., Mao L., Beyers K., McKay A., Ait-Daoud N., Addolorato G., Anton R.F., Ciraulo D.A., Kranzler H.R., Mann K., O'Malley S.S., Swift R.M.
Topiramate in migraine prevention: results of a large controlled trial.
Arch Neurol. 2004 Apr;61(4):490-5. Silberstein S.D., Neto W., Schmitt J., Jacobs D.
Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Arch Gen Psychiatry. 2004 Sep;61(9):905-12. Johnson B.A., Ait-Daoud N., Akhtar F.Z., Ma J.Z.
Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
Neurology. 2006 Aug 8;67(3):400-6. Blum D., Meador K., Biton V., Fakhoury T., Shneker B., Chung S., Mills K., Hammer A., Isojarvi J.
Topiramate for treating alcohol dependence: a randomized controlled trial.
JAMA. 2007 Oct 10;298(14):1641-51. Johnson B.A., Rosenthal N., Capece J.A., Wiegand F., Mao L., Beyers K., McKay A., Ait-Daoud N., Anton R.F., Ciraulo D.A., Kranzler H.R., Mann K., O'Malley S.S., Swift R.M.
Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers.
Neurology. 2005 Mar 8;64(5):792-8. Salinsky M.C., Storzbach D., Spencer D.C., Oken B.S., Landry T., Dodrill C.B.
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.
Neurology. 2003 Aug 26;61(4):456-64. Cudkowicz M.E., Shefner J.M., Schoenfeld D.A., Brown R.H., Johnson H., Qureshi M., Jacobs M., Rothstein J.D., Appel S.H., Pascuzzi R.M., Heiman-Patterson T.D., Donofrio P.D., David W.S., Russell J.A., Tandan R., Pioro E.P., Felice K.J., Rosenfeld J., Mandler R.N., Sachs G.M., Bradley W.G., Raynor E.M., Baquis G.D., Belsh J.M., Novella S., Goldstein J., Hulihan J.
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Pediatrics. 2009 Mar;123(3):924-34. Lewis D., Winner P., Saper J., Ness S., Polverejan E., Wang S., Kurland C.L., Nye J., Yuen E., Eerdekens M., Ford L.
Topiramate for migraine prevention: a randomized controlled trial.
JAMA. 2004 Feb 25;291(8):965-73. Brandes J.L., Saper J.R., Diamond M., Couch J.R., Lewis D.W., Schmitt J., Neto W., Schwabe S., Jacobs D.
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Lancet. 2003 May 17;361(9370):1677-85. Johnson B.A., Ait-Daoud N., Bowden C.L., DiClemente C.C., Roache J.D., Lawson K., Javors M.A., Ma J.Z.
Topiramate in essential tremor: a double-blind, placebo-controlled trial.
Neurology. 2006 Mar 14;66(5):672-7. Epub 2006 Jan 25. Ondo W.G., Jankovic J., Connor G.S., Pahwa R., Elble R., Stacy M.A., Koller W.C., Schwarzman L., Wu S.C., Hulihan J.F.
Topiramate in patients with juvenile myoclonic epilepsy.
Arch Neurol. 2005 Nov;62(11):1705-8. Biton V., Bourgeois B.F.
Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects.
Neurology. 2004 Sep 14;63(5):865-73. Raskin P., Donofrio P.D., Rosenthal N.R., Hewitt D.J., Jordan D.M., Xiang J., Vinik A.I.
Randomized, concentration-controlled trial of topiramate in refractory focal epilepsy.
Neurology. 2003 Nov 11;61(9):1210-8. Christensen J., Andreasen F., Poulsen J.H., Dam M.
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Lancet. 2007 Mar 24;369(9566):1016-26. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., Cramp C., Cockerell O.C., Cooper P.N., Doughty J., Eaton B., Gamble C., Goulding P.J., Howell S.J., Hughes A., Jackson M., Jacoby A., Kellett M., Lawson G.R., Leach J.P., Nicolaides P., Roberts R., Shackley P., Shen J., Smith D.F., Smith P.E., Smith C.T., Vanoli A., Williamson P.R.
Functional outcome measures as clinical trial endpoints in ALS.
Neurology. 2004 Nov 23;63(10):1933-5. Traynor B.J., Zhang H., Shefner J.M., Schoenfeld D., Cudkowicz M.E.
Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.
Am J Cardiol. 2005 Jul 15;96(2):243-51. Tonstad S., Tykarski A., Weissgarten J., Ivleva A., Levy B., Kumar A., Fitchet M.